Transcription of Infection (MDRO/CDI) Module
{{id}} {{{paragraph}}}
January 2022 12-1 Multidrug-Resistant Organism & Clostridioides difficile Infection (MDRO/CDI) Module Table of Contents Background: 2 Table 1. Core and Supplemental Reporting Choices for MDRO and CDI Module 3 Section I: Core Reporting 5 Laboratory-Identified (LabID) Event Reporting 5 1A: MDRO LabID Event Reporting 6 Figure 1. MDRO Test Result Algorithm for All Specimens Laboratory-Identified (LabID) Events 9 Figure 2.
C. Difficile (CDI) Data Analysis: 28 Table 4: Measures Delivered to CMS For Facilities Participating in Quality Reporting Programs MRSA Bloodstream Infection and C. difficile LabID Events 35 Infection Surveillance Reporting 35 2A. MDRO Infection Surveillance Reporting 36 2B. Clostridioides difficile Infection Surveillance Reporting 37 Section II.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Clostridium difficile infection CDI, Difficile Infection, Difficile, Clostridioides(Clostridium)difficile感染症, Clostridium, Infection, Clostridium difficile, Clostridium difficile. infection CDI, PRESCRIBING INFORMATION, Microbiome, Clostridium difficile infection, Clostridium difficile感染症と院内感染対策について, Difficile infection CDI, GUIDELINES FOR TREATMENT OF CLOSTRIDIUM